PLK2 targets GSK3ß to protect against cisplatin-induced acute kidney injury.

Wei, Xiaona; Wu, Jianping; Li, Jiajia; Yang, Qiongqiong

Wei, Xiaona; Wu, Jianping; Li, Jiajia; Yang, Qiongqiong.

Afiliação

Wei X; Department of Nephrology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Wu J; Department of Nephrology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Li J; Department of Nephrology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Yang Q; Department of Nephrology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Electronic address: yangqq@mail.sysu.edu.cn.

Exp Cell Res ; 417(1): 113181, 2022 08 01.

Article em En | MEDLINE | ID: mdl-35523306

Assuntos

Injúria Renal Aguda; Cisplatino; Injúria Renal Aguda/induzido quimicamente; Injúria Renal Aguda/genética; Injúria Renal Aguda/prevenção & controle; Animais; Apoptose; Cisplatino/efeitos adversos; Glicogênio Sintase Quinase 3 beta/genética; Glicogênio Sintase Quinase 3 beta/metabolismo; Rim/metabolismo; Proteínas Serina-Treonina Quinases/genética

Palavras-chave

Acute kidney injury; Apoptosis; Cisplatin; Glycogen synthase kinase 3ß; Oxidative stress; Polo-like kinase 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cisplatino / Injúria Renal Aguda Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google